Marvin Herzberger
Marvin Herzberger is a publishing trader at TraderFox GmbH and group leader for the technical analysis of the DAX. He has been actively engaged in technical analysis since 2011. In this context, he has tested, analyzed, and evaluated various trading strategies in practical implementation. His area of expertise lies in swing trading. The analyses cover a short-term time horizon of up to 10 days.
Latest from Marvin Herzberger
Vusion: The Invisible Conductor in Modern Retail!
Vusion S. A. is a potential hidden champion in the French small-cap sector. The company particularly...
Strategy: New Capital Framework Combines 2.55 Billion USD Reserve with Two Repurchase Programs
Introduction of a framework for active capital management with an established USD reserve of 2.55 billion...
Palantir: Strategic Expansion into Sovereign AI Environments and the Aviation Industry
Provision of Nvidia Nemotron models for secured IT infrastructures Expansion of the partnership with...
Bayer AG: Turnaround and Legal Relief Pave the Way for New Growth
After a landmark ruling by the US Supreme Court in the glyphosate dispute, Bayer AG experiences a significant...
Eupraxia Pharmaceuticals: How Targeted Drug Release Addresses Billion-Dollar Markets – Oppenheimer Sees Massive Price Potential
From Systemic to Local Therapy: The Business Model Eupraxia Pharmaceuticals Inc. (EPRX) is a clinical-stage...
Amazon: Investments, Prime Day Effects, and Insider Sales - Here's What Moves the Stock!
The cloud business is growing while high capital expenditures for AI are reducing cash flow. The...
Targeting the $10 Billion Market: Here's how DraftKings Scales its Business Beyond Traditional Sports Betting with DKeX
Integration of the proprietary exchange DKeX into the existing "Sports & Casino" app infrastructure...
KPN: Defensive Stock Delivers Fresh buy Signals in a Volatile Market Environment!
Currently, some repositioning can be observed in the capital market. Capital is gradually rotating out...
Bitdeer Technologies: Realignment to High-Performance Computing for AI Workloads Boosts Analyst Expectations – Price Target at $35
From Crypto Miner to Vertically Integrated Infrastructure Provider The Bitdeer Technologies Group...
IBM: Technological Advances and Quantum Computing as Growth Drivers
From my perspective, IBM Corp. (IBM) is currently shaping a very exciting story that could offer attractive...
Alibaba: AI Data Dispute with Anthropic and Sanction Concerns - Stock Price Falls to a 16-Month Low!
Stock price has seen a decline of 34% this year due to sanction concerns and allegations of AI data...
SK Hynix Seeks Fresh Capital for AI Infrastructure with Nasdaq Listing
Capital measure aims for $29.4 billion through ADR issuance on Nasdaq Surge in demand for high-bandwidth...
Sol-Gel Technologies: SGT-610 Holds Billion-Dollar Potential in Gorlin Syndrome – Mizuho Recommends Buy
Mizuho initiates Coverage: The investment bank has initiated coverage on Sol-Gel Technologies with...
TKMS: Submarine Specialist Surfaces Thanks to Frigate Fantasy!
TKMS (i.) is a leading niche specialist in the field of non-nuclear powered submarines and a heavyweight...
Twilio: Goldman Sachs sees 57% upside potential thanks to AI transformation - Kickoff for trend continuation!
Goldman Sachs upgrades Twilio to Buy with a price target of $300 and sees structural margin advantages...
IES Holdings: S&P MidCap 400 Inclusion After a Stock Price Rise of Around 1,900% Since Early 2023!
IES Holdings will be added to the S&P MidCap 400 Index on July 1, 2026. The stock price has...
Walmart: Ambitious Transformation into a Technology Platform
The story of Walmart (WMT) is impressive. With strong growth in international e-commerce and the targeted...
Coca-Cola: Potential Tax Liability in the Double-Digit Billion Range Goes to Appeals Court!
20 billion USD tax dispute with the IRS reaches the appeals stage. Company contests changed tax...
D-Wave Quantum: US Government Signs Decrees to Strengthen US Leadership in Quantum Computing!
The US government decrees new funding for quantum computing, boosting the sector and the QBTS stock....
Tenax Therapeutics Approaching Crucial Study Data: Experts See High Potential in the Cardiopulmonary Portfolio
Tenax Therapeutics (TENX) is a biopharmaceutical company in clinical phase 3, focused on the identification...